Ranjit Akolekar

2008–2026 年に発表

119
論文数
18,172
被引用数
67
h 指数
112
i10 指数

被引用数

Ranjit Akolekar の年別被引用数1994 年: 被引用 1 件2007 年: 被引用 1 件2008 年: 被引用 7 件2009 年: 被引用 6 件2010 年: 被引用 39 件2011 年: 被引用 67 件2012 年: 被引用 120 件2013 年: 被引用 112 件2014 年: 被引用 89 件2015 年: 被引用 172 件2016 年: 被引用 120 件2017 年: 被引用 163 件2018 年: 被引用 198 件2019 年: 被引用 721 件2020 年: 被引用 808 件2021 年: 被引用 641 件2022 年: 被引用 508 件2023 年: 被引用 405 件2024 年: 被引用 588 件2025 年: 被引用 343 件2026 年: 被引用 7 件1995〜2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 814 件、この内訳の 15.5%イギリス: 引用元論文 749 件、この内訳の 14.2%中国: 引用元論文 396 件、この内訳の 7.5%オーストラリア: 引用元論文 279 件、この内訳の 5.3%カナダ: 引用元論文 242 件、この内訳の 4.6%イタリア: 引用元論文 221 件、この内訳の 4.2%オランダ: 引用元論文 183 件、この内訳の 3.5%スペイン: 引用元論文 175 件、この内訳の 3.3%ドイツ: 引用元論文 137 件、この内訳の 2.6%香港: 引用元論文 121 件、この内訳の 2.3%フランス: 引用元論文 111 件、この内訳の 2.1%ベルギー: 引用元論文 107 件、この内訳の 2%
0%15.5%その他 32.9%

分野

  • Medicine91%
  • Biochemistry, Genetics and Molecular Biology5%
  • Immunology and Microbiology1.1%
  • Neuroscience0.6%
  • Health Professions0.4%
  • Computer Science0.4%
  • その他1.5%

トピック

  • Pregnancy and preeclampsia studies19.5%
  • Prenatal Screening and Diagnostics8.4%
  • Gestational Diabetes Research and Management7.9%
  • Maternal and fetal healthcare6.2%
  • Birth, Development, and Health6%
  • Fetal and Pediatric Neurological Disorders3.5%
  • その他48.5%

共著者

全論文

検索で開く
  1. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 2,198

  2. Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE

    著者: , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2018 被引用: 380

  3. Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    著者: , , , , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2018 被引用: 430

  4. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

    著者: , , , , , , - American Journal of Obstetrics and Gynecology 2015 被引用: 626

  5. ASPRE trial: performance of screening for preterm pre‐eclampsia

    著者: , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2017 被引用: 459

  6. Competing risks model in screening for preeclampsia by maternal characteristics and medical history

    著者: , , , , - American Journal of Obstetrics and Gynecology 2015 被引用: 420

  7. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia

    著者: , , , , , , , , , , , , , , , , - Circulation 2021 被引用: 116

  8. Fetal Medicine Foundation fetal and neonatal population weight charts

    著者: , , , , - Ultrasound in Obstetrics and Gynecology 2018 被引用: 350

  9. Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus

    著者: , , , , , , , - New England Journal of Medicine 2016 被引用: 389

  10. Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis

    著者: , , , , - Ultrasound in Obstetrics and Gynecology 2015 被引用: 807

  11. Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers

    著者: , , , , - Fetal Diagnosis and Therapy 2012 被引用: 601

  12. Maternal and neonatal complications of fetal macrosomia: systematic review and meta‐analysis

    著者: , , , , , - Ultrasound in Obstetrics and Gynecology 2019 被引用: 302

  13. Diagnosis of fetal non‐chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestation

    著者: , , , , , - Ultrasound in Obstetrics and Gynecology 2019 被引用: 336

  14. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta‐analysis

    著者: , , , , - Ultrasound in Obstetrics and Gynecology 2019 被引用: 356

  15. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing

    著者: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 280

  16. Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

    著者: , , , , , , , , , , , , , , , , - Ultrasound in Obstetrics and Gynecology 2017 被引用: 255

  17. Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis

    著者: , , , , - Ultrasound in Obstetrics and Gynecology 2014 被引用: 730

  18. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks

    著者: , , , , - Prenatal Diagnosis 2010 被引用: 255

  19. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history

    著者: , , , , , , , , , , , , , , , - American Journal of Obstetrics and Gynecology 2017 被引用: 191

  20. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35–37 weeks’ gestation

    著者: , , , , - American Journal of Obstetrics and Gynecology 2019 被引用: 112

  21. First-Trimester Prediction of Hypertensive Disorders in Pregnancy

    著者: , , , , - Hypertension 2009 被引用: 461

  22. Machine learning-enabled maternal risk assessment for women with pre-eclampsia (the PIERS-ML model): a modelling study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jing Li, Kenneth Lim, Sarka Lisonkova, Paula Lott, Jennifer M. Menzies, Alexandra Millman, Lynne Palmer, Beth A. Payne, Ziguang Qu, James A. Russell, Diane Sawchuck, Dorothy Shaw, Douglas K. Still, Ugochinyere Vivian Ukah, Brenda Wagner, Keith R. Walley, Dany Hugo, The late Andrée Gruslin, George Tawagi, Graeme N. Smith, Anne‐Marie Côté, Jean‐Marie Moutquin, Annie Ouellet, Shoo K. Lee, Tao Duan, Jian Zhou, The late Farizah Haniff, Swati Mahajan, Amanda Noovao, Hanna Karjalainend, Alja Kortelainen, Hannele Laivuori, J. Wessel Ganzevoort, Henk Groen, Phillipa M. Kyle, M. Peter Moore, Barbra Pullar, Zulfiqar A Bhutta, Rahat Qureshi, Rozina Sikandar, The late Shereen Z. Bhutta, Garth Cloete, David Hall, The late Erika van Papendorp, D.W. Steyn, Christine Biryabarema, Florence Mirembe, Annettee Nakimuli, John Allotey, Shakila Thangaratinam, K. H. Nicolaides, Olivia Ionescu, Argyro Syngelaki, Michael de Swiet, Laura A. Magee, Peter von Dadelszen, Ranjit Akolekar, James J. Walker, Stephen C. Robson, Fiona Broughton-Pipkin, Pamela Loughna, Manu Vatish, Christopher W.G. Redman, Sarah Barry, Kimberley Kavanagh, Tunde Montgomery-Csobán, Paul Murray, Chris Robertson, Eleni Tsigas, Douglas Woelkers ほか 5 名 - The Lancet Digital Health 2024 被引用: 42

  23. Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio

    著者: , , , , , - Ultrasound in Obstetrics and Gynecology 2018 被引用: 200

  24. Value of routine ultrasound examination at 35–37 weeks' gestation in diagnosis of fetal abnormalities

    著者: , , , , - Ultrasound in Obstetrics and Gynecology 2019 被引用: 107